J Biol Chem, Vol. 274, Issue 32, 22238-22242, August 6, 1999
An Iso-random Bi Bi Mechanism for Adenylate Kinase*
Xiang Rong
Sheng,
Xia
Li, and
Xian Ming
Pan
From the National Laboratory of Biomacromolecules, Institute of
Biophysics, Academia Sinica, Beijing, 100101, China
 |
ABSTRACT |
An iso-random Bi Bi mechanism has been proposed
for adenylate kinase. In this mechanism, one of the enzyme forms can
bind the substrates MgATP and AMP, whereas the other form can bind the
products MgADP and ADP. In a catalytic cycle, the conformational changes of the free enzyme and the ternary complexes are the
rate-limiting steps. The AP5A inhibition equations
derived from this mechanism show theoretically that AP5A
acts as a competitive inhibitor for the forward reaction and a mixed
noncompetitive inhibitor for the backward reaction.
 |
INTRODUCTION |
Adenylate kinase (AK)1
(EC 2.7.4.3) catalyzes the reaction MgATP + AMP
MgADP + ADP, which
is essential for cell survival (1-8). This small kinase has also been
considered as a "model kinase" in the study of the
structure-function relationship of kinases (9). Although the catalytic
kinetics of AK has been studied extensively (10-14), a full
understanding mechanism is still lacking. The basic kinetic
pattern is random Bi Bi (11), but whether the chemical step or the
physical step(s) is rate-limiting is still controversial. Furthermore,
it was reported in an early work of Kuby et al. (12) that
the nature of the AP5A inhibition changes qualitatively
from competitive inhibition with respect to either substrate in the
forward reaction (MgATP or AMP) to noncompetitive (mixed
noncompetitive) in the backward reaction with either substrate (MgADP
or ADP). There is still no convincing explanation for the inhibition
nature of AP5A.
In a series of previous studies in this laboratory, it was found that
there are multiple native forms of AK in equilibrium in solution
(15-18), which may help improve our understanding of the catalytic
mechanism of AK. In this study, the catalysis and inhibition kinetics
of AK was re-examined. An iso-random Bi Bi catalytic mechanism was
proposed. The AP5A inhibition equations derived from this
mechanism show that AP5A acts as a competitive inhibitor
for the forward reaction and a mixed noncompetitive inhibitor for the
backward reaction, agreeing well with experimental results.
 |
EXPERIMENTAL PROCEDURES |
Reagents--
Pyruvate kinase, lactate dehydrogenase,
glucose-6-phosphate dehydrogenase, hexokinase, phosphoenolpyruvate,
NADP, NADH, AMP, ADP, ATP, and AP5A were Sigma products,
and other reagents were local products of analytical grade.
Preparation and Activity Assay of Adenylate Kinase--
The
enzyme was prepared essentially according to Zhang et al.
(19) The yield was usually about 60 mg of pure enzyme per kilogram of
rabbit muscle. The final preparation usually had a specific activity
greater than 1,600 units/mg and showed only a single peak in SDS
electrophoresis, gel filtration, and reversed-phase fast protein liquid
chromatography. One unit is defined as 1 µmol of ADP (MgADP)
generated per minute in forward reaction and 1 µmol of ATP generated
per minute in backward reaction.
Methods--
UV absorbance at 340 nm was measured with either
Cary 219 (Varian) or U-3000 (Hitachi, Japan) spectrophotometer.
The rate of the backward reaction (MgADP + ADP
MgATP + AMP) was
measured by following the reduction of NADP at 340 nm in a coupled
enzyme solution with hexokinase and glucose-6-phosphate dehydrogenase.
The final assay mixture was: 50 mM Tris-HCl, pH 8.1, 2 mM
-mercaptoethanol, 6.7 mM glucose, 0.67 mM NADP, 7.6 µM bovine serum albumin, 10 units/ml hexokinase, 10 units/ml glucose-6-phosphate dehydrogenase,
varying and calculated concentrations of MgAc2, and ADP.
Measurements of the velocity of the forward reaction (MgATP + AMP
MgADP + ADP) was performed by monitoring the oxidation of NADH at 340 nm coupling with pyruvate kinase and lactate dehydrogenase. The final
assay mixture was: 50 mM Tris-HCl, pH 7.5, 2 mM
-mercaptoethanol, 75 mM KCl, 4 mM
phosphoenolpyruvate, 1.0 mM of MgAc2 as free
Mg2+, 0.2 mM NADH, 10 units/ml pyruvate kinase,
20 units/ml lactate dehydrogenase, 7.6 µM bovine serum
albumin, plus varying and calculated amounts of MgAc2, ATP,
and AMP.
Iso-random Bi Bi Mechanism--
The catalysis and inhibition
mechanism of adenylate kinase is suggested as shown Scheme
1.
Using the combined equilibrium and steady-state treatment developed by
Cha (20) and described by Huang (21), Scheme 1 can be reduced to Scheme
2 and Eq. 1.
|
|
|
|
Here E1 and E2
denote two native forms of enzyme, one form (E1)
can bind with AMP (M) and MgATP (T), and the
other one with ADP (D1) and MgADP
(D2). Both interconversions of the ternary complexes and free enzymes are rate-limiting steps. This mechanism is,
in principle, a random Bi Bi type, similar to that proposed by an
earlier study (11), but with the major modification that two native
forms of enzyme are introduced. This mechanism is based on the fact
that AK undergoes large domain movements upon substrate binding (22).
After aligning 17 known structures of nucleoside monophosphate kinases,
Vonrhein et al. (23) gave movies to demonstrate the
catalytic cycle of AK, which showed that the conformation of ternary
complex of enzyme binding with AMP and ATP is different from that of
enzyme binding with two ADP. That is to say, AK undergoes at least two
steps of conformational changes. One step is the change of a ternary
complex with bound substrates to one with bound products during the
reaction, and the other is the change of the free enzyme in different
forms. These conformational changes should be the rate-limiting steps
in the catalytic cycle of AK, whereas the binding of substrates to and
the release of products from the enzyme are quickly equilibrated.
AP5A is composed of ATP and AMP connected by a fifth
phosphate, and mimics both substrates (24). It was assumed that
AP5A (I) can only bind to E1 and the binding reaction of E1 with
AP5A is rapid with an equilibrium constant of
KI. We have also assumed that the affinities for
substrates of free enzyme and binary complexes,
ME1 and E1T, as well as D1E2 and
E2D1, are the same.
|
(Eq. 1)
|
In the forward reaction, one binding site is specific for AMP, whereas
the other less specific one is for MgATP (25), so the reaction system
consists of free enzymes E1 and
E2, binary complexes ME1,
E1M, and
E1T and ternary complexes
ME1T and
ME1M. The products,
D1 and D2, are rapidly
removed by the coupled enzymes, so that the concentration of ternary
complex
D1E1D2
approaches zero.
In the absence of AP5A, we have Eq. 2.
|
(Eq. 2)
|
Here a factor of two is introduced, because the forward reaction
produces two ADP molecules.
In the presence of AP5A, we have Eq. 3.
|
(Eq. 3)
|
Eq. 3 shows that AP5A acts as a competitive
inhibitor for the forward reaction.
In the backward reaction, one binding site is specific for ADP, and the
other less specific one for MgADP (25), so the reaction system consists
of free enzymes E1 and
E2, binary complexes
D1E2, E2D1, and
E2D2, as well as ternary
complexes
D1E2D2
and
D1E2D1. The product ATP is rapidly removed by coupled enzymes, so that the
concentration of ternary complex ME1T
approaches zero. The product conversion was controlled under 10%, and
the concentration of binary complex ME1 could be
considered as zero.
In the absence of AP5A, we have Eq. 4.
|
(Eq. 4)
|
The free concentrations of ADP ([D1])
and MgADP ([D2]) can be calculated from the
total concentrations of ADP
([D1]0)and Mg ([Mg]0) by Eqs. 5 and 6.
|
(Eq. 5)
|
|
(Eq. 6)
|
The stability constant KMg = 2,500 M
1 was used in the calculation (26).
In the presence of AP5A, we have Eq. 7.
|
(Eq. 7)
|
Eq. 7 shows that AP5A acts as a mixed noncompetitive
inhibitor for backward reaction.
 |
RESULTS |
Catalytic Patterns--
Fig. 1,
A and B, shows the catalytic pattern when AMP and
ATP were used as substrates of the forward reaction with the
concentration of magnesium ion kept constant at 1 mM. Fig.
1A shows AMP as the variable substrate, whereas Fig.
1B shows MgATP as the variable substrate. With MgATP
concentration lower than 0.1 mM, the specific activity
increases initially then decreases with increasing concentration of
AMP, implying that AMP can bind to the MgATP site (Fig.
1A).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Catalytic pattern of adenylate kinase at pH
7.4 in the forward reaction. The free magnesium ion concentration
was kept constant at 1 mM. A, AMP as
variable substrate at various fixed MgATP concentrations as indicated;
B, MgATP as variable substrate at various fixed AMP
concentrations as indicated. In all experiments, the final
concentration of adenylate kinase was 2.3 nM unless
otherwise specified.
|
|
In the backward reaction, the concentrations of ADP and MgADP are
dependent on the concentration of magnesium ion. The kinetic measurements were carried out under either varied concentrations of
magnesium ion with constant ADP (Fig.
2A) or varied concentrations of ADP with constant magnesium ion (Fig. 2B). Fig.
2A shows that when ADP concentration is lower than 0.5 mM, the specific activity increases first then decreases
with the increasing concentration of magnesium ion, because the
concentration of MgADP increases with the increasing of magnesium ion
concentration, whereas that of ADP decreases. Fig. 2B shows
that with magnesium ion concentration lower than 0.5 mM,
the specific activity increases first then decreases with increasing
ADP concentrations, implying that ADP can bind to the MgADP site.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
Catalytic pattern of adenylate kinase at pH
8.1 in the backward reaction. A, magnesium ion as
variable substrate at various fixed ADP concentrations as indicated;
B, ADP as variable substrate at various fixed magnesium ion
concentrations as indicated.
|
|
The full set of data in Figs. 1 and 2 was fitted to Eqs. 2 and 4 to
calculate kinetic parameters by a computer program. The best fit
kinetic parameters are summarized in Table
I and were used to draw the solid lines
in Figs. 1 and 2, which are in good agreement with the experimental
results.
View this table:
[in this window]
[in a new window]
|
Table I
Kinetic parameters of adenylate kinase
The Michaelis constants Km equal to the dissociation
constants, i.e. Km(AMP) = KM, Km(MgATP) = KT, Km(ADP) = KD1, Km(MgADP) = KD2, Ki(ADP) = K'D1,
Ki(AP5A) = KI, and
Ki(AMP) = K'M.
|
|
AP5A Inhibition Patterns--
It has been reported by
Kuby et al. (12) that AP5A acts as a competitive
inhibitor for the forward reaction and a noncompetitive inhibitor (the
origin figures show a mixed noncompetitive) for the backward reaction,
here the AP5A inhibition patterns were re-examined.
Because the affinities of AMP to MgATP site as well as ADP to MgADP
site are relatively smaller, Eqs. 10 and 12 can be treated as linear.
Fig. 3, A and B,
shows the AP5A inhibition patterns in the forward reaction
with varied AMP (Fig. 3A) and MgATP (Fig. 3B)
concentrations, respectively, indicating that AP5A acts as a competitive inhibitor for the forward reaction.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
Inhibition pattern of AP5A in the
forward reaction. A, the MgATP concentration was kept
constant at 0.05 mM, and AMP as variable substrate at
various fixed AP5A concentrations as indicated;
B, the AMP concentration was kept at 0.1 mM, and
MgATP as variable substrate at various fixed AP5A
concentrations as indicated.
|
|
Fig. 4, A and B,
shows the AP5A inhibition patterns in the backward reaction
with varied ADP (Fig. 4A) and MgADP (Fig. 4B) concentrations calculated according to Eqs. 3 and 7, respectively, exhibiting that AP5A acts as a mixed noncompetitive
inhibitor for the backward reaction.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
Inhibition pattern of AP5A in the
backward reaction. A, the MgADP concentration was kept
at 0.1 mM, and ADP as variable substrate at various fixed
AP5A concentrations as indicated; B, the ADP
concentration was kept at 0.03 mM, and ADP as variable
substrate at various fixed AP5A concentrations as
indicated.
|
|
A value of KI = 2 ± 0.5 × 10
6 mM was obtained from the full set of data
in Figs. 3 and 4.
 |
DISCUSSION |
There are two nucleotide-binding sites of AK, one for the
magnesium complexes and the other for uncomplexed nucleotides. X-ray and NMR studies suggested that the latter substrate site is more specific, whereas the former can bind uncomplexed substrates to some
extent (24). The above experiments demonstrate that AMP or ADP shows
substrate inhibition in the forward or the backward reaction,
respectively. This result, which was also observed in bakers' yeast AK
by Russell and co-workers (25), is in agreement with the x-ray and NMR findings.
The equilibrium concentrations of E1 and
E2 in the absence of substrates should be
different from those at steady state, so a lag (or burst) phase should
occur in the beginning of the catalytic reaction. However, because the
activity of AK was assayed with a coupled enzyme system, the initial
process is too complicated to follow.
The fact that AP5A acts as a competitive inhibitor for the
forward reaction and a mixed noncompetitive inhibitor for the backward reaction cannot be explained by the normal random Bi Bi mechanism. However, these inhibition patterns are consistent with an iso-random Bi
Bi mechanism in which the substrates can bind to one isoform while the
products bind to another isoform of the enzyme. This strongly supports
the suggestion that two native forms of AK might be involved in the
catalytic reactions.
The rate of enzyme conformational changes is on the order of
102 s
1 in the catalytic reactions, which is
much higher than that determined by ANS fluorescence probe (about
10
2 s
1, see Ref. 15). This perhaps can be
explained that substrates decrease whereas ANS increases the activation
energy of enzyme conformational changes. It was indeed observed that
ANS inhibits the folding of AK, whereas AMP, ADP, and ATP can
accelerate the folding (16). Another possibility is that the two native
forms involved in the catalytic cycle are different from those
distinguished by ANS probe, and AK might exist in more native forms in
equilibrium. The current experimental results provide no information to
distinguish the above possibilities.
It has been reported that some proteins may exist in more than one
distinct folded form in equilibrium. Evidence for distinguishing multiple native forms of staphylococcal nuclease has come from electrophoresis and NMR studies (27-32). For calbindin
D9K, the evidence of multiple forms has come from not only
NMR studies but also from x-ray crystal structures (33, 34). These
results shed light on the understanding of the protein folding problem but give little information on the biological role of the multiple native forms. Is the multiple native forms are necessary for protein to
perform its biological functions or only the results of protein folding? Our results suggest that the multiple native forms are necessary for AK to perform its catalytic function. AK, a small nucleoside monophosphate kinase, undergoes large domain movements during catalysis (23), because it has to shield its active center from
water to avoid ATP hydrolysis. Because the folded forms of AK must be
flexible, multiple native forms with small free energy difference can
exist in equilibrium in the absence of substrates.
In summary, two rate-limiting steps are involved in the catalytic cycle
of AK. Only one form (E1) of AK can bind with
AP5A, so AP5A acts as a competitive inhibitor
for the forward reaction and a noncompetitive inhibitor for the
backward reaction.
 |
ACKNOWLEDGEMENTS |
We express our sincere thanks to Prof.
C. L. Tsou of this institution for reading the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by Grants 39625008 and
39670157 from the National Natural Science Foundation of China and the
Pandeng Project of the China Commission for Science and Technology.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: National Laboratory of
Biomacromolecules, Institute of Biophysics, Academia Sinica, 15 Datun
Rd., Beijing 100101, China. Tel.: 86-10-6488-8497; Fax: 86-10-6487-2026; E-mail: xmpan@sun5.ibp.ac.cn.
 |
ABBREVIATIONS |
The abbreviations used are:
AK, adenylate
kinase;
ANS, 1-anilino-8-naphthalenesulfonate.
 |
REFERENCES |
| 1.
|
Noda, L.
(1973)
in
The Enzymes
(Boyer, P. D., ed), Vol. 8
, pp. 279-305, Academic Press, New York
|
| 2.
|
Atkinson, D. E.
(1977)
Cellular Energy Metabolism and Its Regulation
, pp. 85-107, Academic Press, Orlando, FL
|
| 3.
|
Hamada, M.,
Sumida, M.,
Kurokawa, Y.,
Sunayashiki-Kusuzaki, K.,
Okuda, H.,
Watanabe, T.,
and Kuby, S. A.
(1985)
J. Biol. Chem.
260,
11595-11602[Abstract/Free Full Text]
|
| 4.
|
Miwa, S.,
Fujii, H.,
Tani, K.,
Takahashi, K.,
Tanizawa, T.,
and Igarashi, T.
(1983)
Am. J. Hematol.
14,
325-333[Medline]
[Order article via Infotrieve]
|
| 5.
|
Matsuura, S.,
Igarashi, M.,
Tanizawa, Y.,
Yamada, M.,
Kishi, F.,
Kajii, T.,
Fujii, H.,
Miwa, S.,
Sakurai, M.,
and Nakazawa, A.
(1989)
J. Biol. Chem.
264,
10148-10155[Abstract/Free Full Text]
|
| 6.
|
Toren, A.,
Brok-Simoni, F.,
Ben-Bassat, I.,
Holtzman, F.,
Mandel, M.,
Neumann, Y.,
and Ramot, B.
(1994)
Br. J. Haematol.
87,
376-380[Medline]
[Order article via Infotrieve]
|
| 7.
|
Qualtieri, A.,
Pedace, V.,
Bisconte, M. G.,
Bria, M.,
Gulino, B.,
Andreoli, V.,
and Brancati, C.
(1997)
Br. J. Haematol.
99,
770-776[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Thomas, G.,
and Murthy, W.
(1997)
J. Clin. Lab. Anal.
11,
351-356[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Tsai, M.-D.,
and Yan, H. G.
(1991)
Biochemistry
30,
6806-6818[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Callaghan, O. H.,
and Weber, G.
(1959)
Biochem. J.
73,
473-485[Medline]
[Order article via Infotrieve]
|
| 11.
|
Rhoads, D. G.,
and Lowenstein, J. M.
(1968)
J. Biol. Chem.
243,
3963-3972[Abstract/Free Full Text]
|
| 12.
|
Kuby, S. A.,
Hamada, M.,
Gerber, D.,
Tsai, W. C.,
Jacobs, H. K.,
Cress, MC.,
Chua, G. K.,
Fleming, G.,
Wu, L. H.,
Fischer, A. H.,
Frischat, A.,
and Maland, L.
(1978)
Arch. Biochem. Biophys.
187,
34-52[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Hamada, M.,
and Kuby, S. A.
(1978)
Arch. Biochem. Biophys.
190,
772-792[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Hamada, M.,
Paimieri, R. H.,
Russell, G. A.,
and Kuby, S. A.
(1979)
Arch. Biochem. Biophys.
195,
155-177[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Zhang, H. J.,
Sheng, X. R.,
Niu, W. D.,
Pan, X. M.,
and Zhou, J. M.
(1998)
J. Biol. Chem.
273,
7448-7456[Abstract/Free Full Text]
|
| 16.
|
Zhang, H. J.,
Sheng, X. R.,
Pan, X. M.,
and Zhou, J. M.
(1998)
Biochem. J.
333,
401-405
|
| 17.
|
Sheng, X. R.,
Zhang, H. J.,
Pan, X. M.,
and Zhou, J. M.
(1997)
FEBS Lett.
413,
429-432[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Zhang, H. J.,
Sheng, X. R.,
Pan, X. M.,
and Zhou, J. M.
(1997)
Biochem. Biophys. Res. Commun.
238,
382-386[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Zhang, Y. L.,
Zhou, J. M.,
and Tsou, C. L.
(1993)
Biochim. Biophys. Acta
1164,
61-67[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Cha, S.
(1968)
J. Biol. Chem.
243,
820-825[Abstract/Free Full Text]
|
| 21.
|
Huang, C. Y.
(1979)
in
Methods in Enzymology
(Purich, D. L., ed), Vol. 63
, pp. 54-84, Academic Press, New York
|
| 22.
|
Schulz, G. E.,
Müller, C. W.,
and Diederich, K.
(1990)
J. Mol. Biol.
213,
627-630[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Vonrhein, C.,
Schlauderer, G. J.,
and Schulz, G. E.
(1995)
Structure
3,
483-490[Medline]
[Order article via Infotrieve]
|
| 24.
|
Lienhard, G. E.,
and Secemski, I. I.
(1973)
J. Biol. Chem.
248,
1121-1123[Abstract/Free Full Text]
|
| 25.
|
Khoo, J. C.,
and Russell, P. J., Jr.
(1970)
J. Biol. Chem.
245,
4163-4167[Abstract/Free Full Text]
|
| 26.
|
Kuby, S. A.,
and Noltman, E. A.
(1962)
in
The Enzymes
(Boyer, P. D.
, Lardy, H. A.
, and Myrback, K., eds), Ed. 2, Vol. 6
, pp. 515-603, Academic Press, New York
|
| 27.
|
Taniuchi, H.,
and Anfinsen, C. B.
(1966)
J. Biol. Chem.
241,
4366-4385[Abstract/Free Full Text]
|
| 28.
|
Markley, J. L.,
Williams, M. N.,
and Jardetzky, O.
(1970)
Proc. Natl. Acad. Sci. U. S. A.
65,
645-651[Abstract/Free Full Text]
|
| 29.
|
Arata, Y.,
Khalifah, R.,
and Jardetzky, O.
(1973)
Ann. N. Y. Acad. Sci.
222,
230-239[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Tucker, P. W.,
Hazen, E. E.,
and Cotton, F. A.
(1978)
Mol. Cell. Biochem.
22,
67-77[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Evans, P. A.,
Dobson, C. M.,
Kautz, R. A.,
Hatfull, G.,
and Fox, R. O.
(1987)
Nature
329,
266-268[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Evans, P. A.,
Kautz, R. A.,
Fox, R. O.,
and Dobson, C. M.
(1989)
Biochemistry
28,
362-370[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Chazin, W. J.,
Kördel, J.,
Drakenberg, T.,
Thulin, E.,
Hofmann, T.,
and Forsén, S.
(1989)
Proc. Natl. Acad. Sci., U. S. A.
86,
2195-2198[Abstract/Free Full Text]
|
| 34.
|
Svensson, L. A.,
Thulin, E.,
and Forsén, S.
(1992)
J. Mol. Biol.
223,
601-606[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Arora and C. L. Brooks III
Large-scale allosteric conformational transitions of adenylate kinase appear to involve a population-shift mechanism
PNAS,
November 20, 2007;
104(47):
18496 - 18501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bellinzoni, A. Haouz, M. Grana, H. Munier-Lehmann, W. Shepard, and P. M. Alzari
The crystal structure of Mycobacterium tuberculosis adenylate kinase in complex with two molecules of ADP and Mg2+ supports an associative mechanism for phosphoryl transfer
Protein Sci.,
June 1, 2006;
15(6):
1489 - 1493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Castellanos, D. B. Wilson, and M. L. Shuler
A modular minimal cell model: Purine and pyrimidine transport and metabolism
PNAS,
April 27, 2004;
101(17):
6681 - 6686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Haouz, V. Vanheusden, H. Munier-Lehmann, M. Froeyen, P. Herdewijn, S. Van Calenbergh, and M. Delarue
Enzymatic and Structural Analysis of Inhibitors Designed against Mycobacterium tuberculosis Thymidylate Kinase. NEW INSIGHTS INTO THE PHOSPHORYL TRANSFER MECHANISM
J. Biol. Chem.,
February 7, 2003;
278(7):
4963 - 4971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Roman, R. A. Meyer, and R. W. Wiseman
Phosphocreatine kinetics at the onset of contractions in skeletal muscle of MM creatine kinase knockout mice
Am J Physiol Cell Physiol,
December 1, 2002;
283(6):
C1776 - C1783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Markaryan, O. Zaborina, V. Punj, and A. M. Chakrabarty
Adenylate Kinase as a Virulence Factor of Pseudomonas aeruginosa
J. Bacteriol.,
June 1, 2001;
183(11):
3345 - 3352.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.